{"id":372394,"title":"Draft guidance document: Labelling of pharmaceutical drugs for human use - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:48:27.690000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/draft-labelling-pharmaceutical-drugs-human-use.html","snippet":"Draft guidance document: Labelling of pharmaceutical drugs for human use Download in PDF format (1.06 MB, 65 pages) Organization: Health Canada Date published: 2022-12-21 Date adopted: 11-01-2013 Effective date: 06-13-2015 Date revised: 12-17-2022 The following guidance document…","rawSnapshotUrl":"/api/snapshots/raw/372394","browseUrl":"https://replay.healtharchive.ca/job-6/20260411164827/https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/draft-labelling-pharmaceutical-drugs-human-use.html#ha_snapshot=372394","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}